HeLa and A549 |
95 |
Loss-of-function by miRNA inhibitors |
Cell proliferation and apoptosis |
Cell counting and caspase-3/7 activity assay |
2005 |
[100] |
|
Primary hTERT-immortalized BJ-EHT fibroblasts |
~450 |
Gain-of-function by stable miRNA expression |
Sustained proliferation |
miR-Array |
2006 |
[40] |
|
HeLa |
~450 |
Gain-of-function by stable miRNA expression |
p27Kip1 regulation |
GFP reporter assay and miR-Array |
2007 |
[45] |
|
MDA-MB-453 |
187 |
Gain-of-function by miRNA precursors |
TRAIL-induced caspase-3 activation |
Caspase-3/7 activity assay |
2007 |
[104] |
|
Drosophila clone 8 cells |
77/78 miRNA loci |
Gain-of-function by plasmid-based miRNA expression |
Wg signaling pathway regulation |
Luciferase reporter assay |
2007 |
[110] |
|
Neuroblastoma cell lines |
8 |
Gain- and loss-of-function by miRNA mimics and inhibitors |
Proliferation |
Change in electrical impedance |
2008 |
[111] |
|
MCF7 |
~450 |
Gain-of-function by stable miRNA expression |
Cell migration |
Trans-well cell migration assay |
2008 |
[101] |
|
HeLa |
91 |
Gain-of-function by miRNA mimics |
p53 gene activity |
Luciferase reporter assay |
2009 |
[38] |
|
HeLa |
~450 |
Gain-of-function by stable miRNA expression |
Per gene family regulation |
GFP reporter assay and miR-Array |
2009 |
[102] |
|
Primary ovarian granulosa cells |
80 |
Gain-of-function by miRNA precursors |
Progesterone, testosterone and estradiol release |
Enzyme immunoassay (EIA) |
2009 |
[112] |
|
HEK 293 |
266 |
Gain-of-function by miRNA mimics |
p21Cip/Waf1 regulation |
Luciferase reporter assay |
2010 |
[46] |
|
HCT-16 |
810 |
Gain-of-function by miRNA mimics |
Cell viability in the presence of Bcl-2 family inhibitor ABT-263 |
CellTiter-Glo Luminescent Cell Viability Assay |
2010 |
[99] |
|
HEK 293T |
107 |
Gain-of-function by miRNA mimics |
p53 gene regulation |
Luciferase reporter assay |
2010 |
[39] |
|
HCT116 p53+/+, H460 and MCF7 |
5 |
Gain-of-function by miRNA precursors |
p53 gene regulation |
Western blot |
2010 |
[10] |
|
Huh-7 |
327 |
Gain-of-function by miRNA precursors |
Lipid droplet formation and growth |
Immunocytochemistry and fluorescence microscopy |
2010 |
[105] |
|
Primary ovarian granulosa cells |
80 |
Gain-of-function by miRNA precursors |
Proliferation and apoptosis |
Immunocytochemistry and fluorescence microscopy |
2010 |
[113] |
|
DLD-1 |
319 |
Gain-of-function by miRNA precursors |
Cell viability |
CellTiter-Glo Luminescent Cell Viability Assay |
2010 |
[11] |
|
HMEC |
328 |
Gain-of-function by miRNA precursors |
Proliferation |
Fluorescence microscopy |
2010 |
[114] |
|
MIA PaCa-2 |
445 |
Gain-of-function by stable miRNA expression |
Proliferation |
Custom-made microarray |
2010 |
[115] |
|
HeLa and HeLa P4 |
8 |
Gain- and loss-of-function by miRNA precursors and inhibitors |
Cell proliferation and trafficking |
Fluorescence microscopy |
2011 |
[116] |